A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay. - sprookjes - yvandenbroek - TriplyDB

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

http://www.wikidata.org/entity/Q35528326

about

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults Diagnostic 'omics' for active tuberculosis Point-of-care diagnosis of tuberculosis: past, present and future Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce Performance of Xpert MTB/RIF in the diagnosis of tuberculous mediastinal lymphadenopathy by endobronchial ultrasound.Multicenter feasibility study to assess external quality assessment panels for Xpert MTB/RIF assay in South Africa Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapse.Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study.GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings A Novel Sample Processing Method for Rapid Detection of Tuberculosis in the Stool of Pediatric Patients Using the Xpert MTB/RIF Assay The use of digital PCR to improve the application of quantitative molecular diagnostic methods for tuberculosis Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB.Performance of Xpert MTB/RIF Assay in Diagnosis of Pleural Tuberculosis by Use of Pleural Fluid Samples Prevalence and clinical relevance of helminth co-infections among tuberculosis patients in urban Tanzania.The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates.Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?Direct comparison of Xpert MTB/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activity.Blood transcriptomic diagnosis of pulmonary and extrapulmonary tuberculosis.Exploring alternative biomaterials for diagnosis of pulmonary tuberculosis in HIV-negative patients by use of the GeneXpert MTB/RIF assay.Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure.Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments.Update in tuberculosis and nontuberculous mycobacterial disease 2011.The early bactericidal activity of antituberculosis drugs.Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi.Assessment of the quantitative ability of AdvanSure TB/NTM real-time PCR in respiratory specimens by comparison with phenotypic methods XtracTB Assay, a Mycobacterium tuberculosis molecular screening test with sensitivity approaching culture.Editorial Commentary: 1, 2, 3 (Years) … and You're Out: The End of a 123-year Historic Era.Genetic Mimetics of Mycobacterium tuberculosis and Methicillin-Resistant Staphylococcus aureus as Verification Standards for Molecular Diagnostics.Molecular Biosensors for Electrochemical Detection of Infectious Pathogens in Liquid Biopsies: Current Trends and Challenges.False positive Xpert MTB/RIF results in re-tested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes.Correlation of Xpert MTB/RIF with measures to assess Mycobacterium tuberculosis bacillary burden in high HIV burden areas of Southern Africa.Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial Evaluation of Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in stool samples of adults with pulmonary tuberculosis

P2860

Q24200879-22FB1CFE-2219-47DE-9017-1E976B80A535 Q24201466-97495F39-A198-4746-8311-E56FF4943A79 Q26752536-A5996C1E-0911-49F4-B755-745E9440F006 Q27004667-7ACD5025-BA78-4788-9C4B-EBBE0DB5D3DE Q28533713-2FA9CFE7-8ED9-4BE9-BEAA-62CE57E0D6B1 Q28727351-7F234D3C-43BF-4214-BB3E-BEAF2683715C Q33640495-7D17C8A0-7A22-47A6-A116-19AE91D5C674 Q33900136-0CC2E7A6-BCBA-40DF-B991-6C25D6084118 Q33901601-092F19C8-3E63-4EC0-82B1-AF57B92F3146 Q34718431-9D1E0302-5778-435D-85A2-9C0007FAFB5D Q35027615-0F193BA9-0491-4E82-B028-D0BC12B9C189 Q35772420-52D009B2-3419-4D0B-8BBA-CB930D52ADDE Q35967658-72AC9933-1A95-4C44-8FF1-3CB5564532CA Q36094092-DFB29C4F-7FF6-457B-8D1D-726B21D1A3FA Q36100081-309478DF-C80C-466A-AB3F-6D28DEB600B9 Q36173984-386F38C8-2BCF-43B2-AFD3-BA9959B09AE8 Q36274227-C1F57B3B-DCCC-4F5B-BD55-B01933E0BBFC Q36564933-F2EA7B57-D7FB-42E0-99CD-AEAB3E575CB1 Q36715814-7D4947DD-A70B-47E8-ABCA-DB9DF1EF402E Q37026368-CBC47ACC-2673-40D0-8D4F-BE5D10BAB080 Q37316234-223EE7FE-AA8F-4971-B2AC-B7E7A1DF53C9 Q37336296-D3CD894D-B5BA-4EDF-A5CF-D74D219387B5 Q37434341-D5321A31-3311-4F54-BFB0-4D72F29A21B3 Q37732922-091F070B-4F53-4849-A06A-38E3185D5731 Q38019488-14C2589E-CDD9-4DED-ABD8-8D121CDDE62A Q38176039-51BBC0AB-91AC-4B07-B50A-A6DCA3807DC4 Q41103344-E158B88E-A384-4B0D-ACF4-FFFD8184A284 Q41860621-C694DE95-5E2A-41E9-B23A-A55653FDF6FB Q42090542-19C29973-16A0-4779-8984-B182EF7A6710 Q44598901-E08491B8-61F2-4DC1-92E3-639DCC7A60C8 Q46313072-9741984B-2E31-4E78-8E02-E3406CB7F59D Q47143759-C28F3904-1681-4F28-8FA3-194E86C7F925 Q47203491-8FFA6C8E-9936-46CA-B0F0-B7BD961845E6 Q54957532-C448740F-53AA-4E4F-9118-44DD4CB32A23 Q57276328-2EDA2D7B-3458-443A-A1A3-C73B3DE2EA8B Q57927358-4C450AFA-5B84-4C5C-8F1A-841720C93D03

P2860

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

http://www.wikidata.org/entity/Q35528326

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

@ast

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

@en

type

label

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

@ast

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

@en

prefLabel

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

@ast

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

@en

P1433

Q35528326-3266327A-80C9-4569-ABD0-DD4535F8D685

P1476

Q35528326-3371892C-9ABF-4872-BB47-F0D8BFBD341A

P2093

Q35528326-042BA4C8-C5F7-4C27-942D-B216D3F09F7C

Q35528326-13D5CF4A-B967-4ECA-90FA-F690B52EBBDF

Q35528326-16178AF1-FA6B-4066-8345-3E7D7E94A52D

Q35528326-612E83EE-EF10-4C60-BF51-05CA0521543B

Q35528326-6E49FE97-5A89-46F8-A81F-4524D620C016

Q35528326-8F4C7524-8DCD-403E-BE80-038FFE2E69CA

Q35528326-9235B9C1-3781-47D2-865D-1D350D57C62D

Q35528326-92C697D8-BDC7-4DF6-A55D-E7AF06F5D5F2

Q35528326-9A935E3D-31BE-4E2D-A9DD-A50A43629EE4

Q35528326-AA4126D5-254D-4661-BE3B-FEEBBAF67A94

P2860

Q35528326-032A65A1-992A-43D2-BDDF-207F5D63D90C

Q35528326-0537CD1C-B85E-4585-9922-7381F695F00F

Q35528326-0B1E8C43-2C06-4642-8021-4B69A77896A0

Q35528326-1980A94A-2A31-414C-8943-FBD95E424A82

Q35528326-24808B20-B3A8-447B-A987-A34889235EE8

Q35528326-28399AEE-8C74-4DA7-BAEC-E52FAF8E0397

Q35528326-4C5DD5BC-8D14-42D7-9B61-51C6A5B89423

Q35528326-4D11C1B1-F151-47FC-BBAB-D37B7A9F489C

Q35528326-51AE78DB-4170-4131-A068-9C38CF808C67

Q35528326-51B7DDD1-9025-497A-A193-864A091537F4

P304

Q35528326-F2FEDE8E-BA57-4576-9B0C-1B55A58B983F

P31

Q35528326-AA07B304-F5BC-4BFC-8035-7D221588F2DB

P356

Q35528326-5EF721E0-249F-4799-85F2-6711AAA39012

P407

Q35528326-B2B3F55D-1B3B-4E47-A5D0-74A42AD6F702

P433

Q35528326-25B1DD6F-6C8C-46EC-8DD4-0DE0207C3F12

P478

Q35528326-0955CB67-8483-4335-B145-57834217D01A

P50

Q35528326-1AAE91EA-0350-40E1-B844-2FDD73734CB7

Q35528326-41312E9F-5291-4C23-8405-8F26EA131290

Q35528326-B1AB479D-DA14-40A0-A1B5-92EB9CAFF37B

P577

Q35528326-0B5DCF13-A399-4E21-9BA1-82782D1D7C05

P698

Q35528326-A37F89CA-DB75-4209-A427-3AE244984C8A

P932

Q35528326-97A6C084-5311-42A8-9A9A-FC5BD91618D9

P356

RCCM.201103-0536OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

@en

P2093

Camilla Rodrigues

http://www.w3.org/2001/XMLSchema#string

Catharina C Boehme

http://www.w3.org/2001/XMLSchema#string

David Alland

http://www.w3.org/2001/XMLSchema#string

David H Persing

http://www.w3.org/2001/XMLSchema#string

Doris Hillemann

http://www.w3.org/2001/XMLSchema#string

Felicity Leisegang

http://www.w3.org/2001/XMLSchema#string

Mark D Perkins

http://www.w3.org/2001/XMLSchema#string

Martin Jones

http://www.w3.org/2001/XMLSchema#string

Pamela Nabeta

http://www.w3.org/2001/XMLSchema#string

Rasim Tahirli

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This st

Rapid molecular detection of tuberculosis and rifampin resistance

Better patient instruction for sputum sampling can improve microscopic tuberculosis diagnosis.

Insufficient quality of sputum submitted for tuberculosis diagnosis and associated factors, in Klaten district, Indonesia.

Extensive cross-contamination of specimens with Mycobacterium tuberculosis in a reference laboratory.

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

Time to detection of Mycobacterium tuberculosis as an alternative to quantitative cultures.

Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.

Evaluation of the analytical performance of the Xpert MTB/RIF assay.

Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli.

P304

1076-1084

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201103-0536OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

184

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21836139

http://www.w3.org/2001/XMLSchema#string

P932

3208646

http://www.w3.org/2001/XMLSchema#string